000			01968 a2200517 4500
005			20250516143932.0
264		0	_c20140310
008			201403s 0 0 eng d
022			_a1533-4023
024	7		_a10.1097/FJC.0b013e31829497ea _2doi
040			_aNLM _beng _cNLM
100	1		_aHai-Mei, Liu
245	0	0	_aAndrographolide protects against lipopolysaccharide-induced vascular hyporeactivity by suppressing the expression of inducible nitric oxide in periaortic adipose. _h[electronic resource]
260			_bJournal of cardiovascular pharmacology _cAug 2013
300			_a154-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdipose Tissue, White _xdrug effects
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aAorta, Thoracic _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDiterpenes _xtherapeutic use
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aDrug Resistance _xdrug effects
650	0	4	_aEndotoxemia _xdrug therapy
650	0	4	_aLipopolysaccharides
650	0	4	_aMale
650	0	4	_aMuscle Contraction _xdrug effects
650	0	4	_aMuscle, Smooth, Vascular _xdrug effects
650	0	4	_aNitric Oxide Synthase Type II _xantagonists & inhibitors
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aRandom Allocation
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aShock, Septic _xetiology
650	0	4	_aVasoconstrictor Agents _xpharmacology
650	0	4	_aVasodilator Agents _xpharmacology
700	1		_aSong-Yin, Huang
700	1		_aRun-Mei, Li
700	1		_aXiao-Huang, Xu
700	1		_aLe-Quan, Zhou
700	1		_aXiao-Ping, Lai
700	1		_aJin-Wen, Xu
773	0		_tJournal of cardiovascular pharmacology _gvol. 62 _gno. 2 _gp. 154-9
856	4	0	_uhttps://doi.org/10.1097/FJC.0b013e31829497ea _zAvailable from publisher's website
999			_c22659093 _d22659093